The use of a cannabis spray as part of the treatment plan for certain patients with cancer is taking another step forward with the announcement of continued clinical research by the New South Wales-based Medlab Clinical LTD. The phase I study is being led by Professor Stephen Clarke and has
In another historic first for advancing research into the uses of cannabis for pharmaceutical purposes, the University of Washington (UW) has entered into a deal with Canadian-based Pascal Biosciences. Negotiated by CoMotion, UW’s incubation group, the partnership involves UW licensing a cannabinoid-based compound, ST-403 (ST) for use in various pharma products.
According to a recent article posted in the Pain News Network, clinical trials involving the study of cannabis and CBD in a variety of interventional settings are expected to take off now that regulations around such investigations seem to be loosening up for the Canadian and U.S.-based research communities thanks